The Src Family Kinase/Abl Inhibitor Dasatinib Suppresses Proliferation and Enhances Differentiation of Osteoblasts

類似資料

• Endothelial-to-osteoblast conversion generates osteoblastic metastasis of prostate cancer
  著者:: Lin, Song-Chang, 等
  出版事項: (2017)
• Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts
  著者:: Huang, Chih-Fen, 等
  出版事項: (2010)
• Osterix and NO66 histone demethylase control the chromatin architecture of Osterix target genes during osteoblast differentiation
  著者:: Sinha, Krishna M., 等
  出版事項: (2014)
• The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts
  著者:: Id Boufker, Hichame, 等
  出版事項: (2010)
• Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model.
  著者:: Aaron J Scott, 等
  出版事項: (2017-01-01)